Association of positive ranges of p53 expression, TP53 gene mutation, and the incidence of regional lymph node metastasis and/or postoperative recurrence in patients with endometrial endometrioid carcinoma. The gene discussed is TP53; the disease is endometrial endometrioid carcinoma.